Prothena Corporation plc (PRTA)

Chimerix Revenue by Segment

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Collaboration	137.89M	135.11M	133.30M	217.20M	-	91.32M	100.93M	17.58M
Collaboration Growth	-	47.95%	32.08%	1,135.61%	-	559.11%	1,877.41%	-78.58%
License and Intellectual Property	50.00K	-	-	-	50.00K	-	-	-
License and Intellectual Property Growth	-	-	-	-	-99.88%	-	-	-

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.